Cell Culture Company (C3) is unique among CDMOs. They have the capability to deliver innovative and scalable GMP custom mammalian and insect cell culture services from preclinical development to commercialization. To accomplish this, They employ traditional cell culture methods as well as automated, single-use, perfusion bioreactors. For more than 30 years, They have been focused on providing the right solutions to support research, clinical trials, and commercialization of regulated biologics for the diagnostic, therapeutic, animal health, and food safety industries.